Skip to main content

(Approval lapsed) Stemetil prochlorperazine 12.5mg/1mL solution for injection ampoule (New Zealand)

Section 19A approved medicine
(Approval lapsed) Stemetil prochlorperazine 12.5mg/1mL solution for injection ampoule (New Zealand)
Section 19A approval holder
Medsurge Healthcare Pty Ltd ABN 92 124 728 892
Phone
1300 788 261
Approved until
Status
Expired
Medicines in short supply/unavailable
STEMETIL prochlorperazine mesilate 12.5mg/1mL injection ampoule - ARTG 27555
Indication(s)

Nausea and vomiting due to various causes including migraine; vertigo due to Meniere's syndrome, labyrinthitis and other causes.

Images
Picture of Stemetil prochlorperazine 12.5mg/1mL solution for injection ampoule - box

Help us improve the Therapeutic Goods Administration site